Qube Research & Technologies (QRT)
CORT icon

Qube Research & Technologies (QRT)’s Corcept Therapeutics CORT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-225,382
Closed -$16.5M – 3626
2025
Q2 		$16.5M Sell
225,382
-77,539
-26% -$5.62M 0.02% 987
2025
Q1 		$34.6M Sell
302,921
-109,338
-27% -$6.65M 0.04% 530
2024
Q4 		$20.8M Buy
412,259
+353,730
+604% +$18.5M 0.03% 706
2024
Q3 		$2.71M Buy
+58,529
New +$2.08M ﹤0.01% 1645
2024
Q2 		– Sell
-143,747
Closed -$3.62M – 3929
2024
Q1 		$3.62M Buy
+143,747
New +$3.4M 0.01% 1410
2023
Q4 		– Sell
-2,009
Closed -$54.7K – 4394
2023
Q3 		$54.7K Sell
2,009
-103,442
-98% -$2.99M ﹤0.01% 2847
2023
Q2 		$2.35M Buy
105,451
+75,650
+254% +$1.74M 0.01% 984
2023
Q1 		$645K Sell
29,801
-106,963
-78% -$2.34M ﹤0.01% 1466
2022
Q4 		$2.78M Buy
136,764
+59,881
+78% +$1.5M 0.01% 834
2022
Q3 		$1.97M Buy
76,883
+45,079
+142% +$1.21M 0.01% 929
2022
Q2 		$756K Sell
31,804
-8,762
-22% -$191K 0.01% 1218
2022
Q1 		$914K Sell
40,566
-1,659
-4% -$35.3K 0.01% 1216
2021
Q4 		$836K Buy
42,225
+12,560
+42% +$255K 0.01% 1297
2021
Q3 		$584K Buy
+29,665
New +$621K 0.01% 1135
2021
Q2 		– Sell
-15,935
Closed -$379K – 2339
2021
Q1 		$379K Buy
+15,935
New +$425K 0.01% 1332
2020
Q3 		– Sell
-21,070
Closed -$354K – 1734
2020
Q2 		$354K Buy
21,070
+8,068
+62% +$113K 0.01% 1236
2020
Q1 		$155K Buy
+13,002
New +$161K 0.01% 916

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CORT Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Corcept Therapeutics (CORT) in Q3 2025, closing a stake of 225,382 shares — an estimated $16.5M sold.

Qube Research & Technologies (QRT) first reported a position in CORT in Q1 2020 and held it in 17 quarters. The position peaked at $34.6M in Q1 2025. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Corcept Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 225,382 Corcept Therapeutics shares in Q3 2025, an estimated $16.5M.
  • Qube Research & Technologies (QRT) first reported a position in Corcept Therapeutics in Q1 2020 and held it in 17 quarters.
  • Qube Research & Technologies (QRT)'s Corcept Therapeutics position peaked at $34.6M in Q1 2025.
  • 429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.